Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perfluorohexyloctane Eye Drops for Post‑Cataract Dry Eye
ChiCTR2600130466Phase 4Not yet recruiting
- Sponsor
- Eye Hospital Affiliated to Shandong University of Traditional Chinese Medicine
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of perfluorohexyloctane in dry eye syndrome (DED) and senile cataract (ARC) (2 arms), sponsored by Eye Hospital Affiliated to Shandong University of Traditional Chinese Medicine. Primary endpoint: Tear Break-Up Time (BUT). Planned start Aug 2026; status: not yet recruiting.
02
Drugs
perfluorohexyloctane
03
Conditions
dry eye syndrome (DED)senile cataract (ARC)
Beyond the preview
Go deeper on ChiCTR2600130466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600130466.